About Grifols

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. Our four divisions ā€“ Bioscience, Diagnostic, Hospital and Bio Supplies ā€“ develop, produce, and market innovative solutions and services in more than 110 countries.

Pioneers in the plasma industry, Grifols continues to grow its network of donation centers, the worldā€™s largest. It transforms collected plasma into essential medicines to treat chronic, rare, prevalent and, at times, life-threatening conditions. To ensure a safe and consistent source of plasma-derived medicines worldwide, we have a vertically integrated production process, from plasma collection through fractionation and purification.

Key essential plasma-derived products include immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and specialty hyperimmune globulins.

Grifols, with more than 23,000 employees in more than 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership.

For more information, please visit grifols.com